Letter to the editor: The J-shaped 25-hydroxyvitamin D concentration-cardiovascular disease mortality relation is very likely due to starting vitamin D supplementation late in life

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 6, 2015, Pages L49-L50

  Grant, William B ^a  

^a Sunlight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; FOLLOW UP; FRAIL ELDERLY; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; FEMALE; MALE; MORTALITY; VITAMIN D DEFICIENCY;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84930806251     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1554     Document Type: Letter

References (10)

1. Durup D, Jørgensen HL, Christensen J, et al. A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study. J Clin Endocrinol Metab. 2015; doi:10.1210/jc.2014-4551. Medline
2. Ensrud KE, Blackwell TL, Cauley JA, et al. Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J Am Geriatr Soc. 2011;59:101-106. CrossRef, Medline, ISI
3. Ensrud KE, Ewing SK, Fredman L, et al. Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab. 2010;95:5266-5273. Abstract, Medline, ISI
4. Reinikainen J, Laatikainen T, Karvanen J, Tolonen H. Lifetime cumulative risk factors predict cardiovascular disease mortality in a 50-year follow-up study in Finland. Int J Epidemiol. 2015;44:108-116. CrossRef, Medline, ISI
5. Grant WB. Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol. 2012;4:198-202. CrossRef
6. Wang L, Song Y, Manson JE, et al. Circulating 25hydroxyvitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819-829. CrossRef
7. Garland CF, Kim JJ, Mohr SB, et al. Meta-analysis of all-cause mortality according to serum 25hydroxyvitamin D. Am J Public Health. 2014;104:e43-e50. CrossRef, Medline, ISI
8. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2011;96:1911-1930. Abstract, Medline, ISI
9. Płudowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64:319-327. CrossRef, Medline
10. Engelsen O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients. 2010;2:482-495. CrossRef